CRSP
Price
$47.91
Change
-$2.52 (-5.00%)
Updated
Feb 21 closing price
Capitalization
4.11B
78 days until earnings call
RGNX
Price
$7.27
Change
-$0.09 (-1.22%)
Updated
Feb 21 closing price
Capitalization
360.69M
9 days until earnings call
Ad is loading...

CRSP vs RGNX

Header iconCRSP vs RGNX Comparison
Open Charts CRSP vs RGNXBanner chart's image
CRISPR Therapeutics AG
Price$47.91
Change-$2.52 (-5.00%)
Volume$2.68M
Capitalization4.11B
REGENXBIO
Price$7.27
Change-$0.09 (-1.22%)
Volume$632.91K
Capitalization360.69M
CRSP vs RGNX Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. RGNX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and RGNX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CRSP: $52.22 vs. RGNX: $7.58)
Brand notoriety: CRSP and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 274% vs. RGNX: 57%
Market capitalization -- CRSP: $4.11B vs. RGNX: $360.69M
CRSP [@Biotechnology] is valued at $4.11B. RGNX’s [@Biotechnology] market capitalization is $360.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while RGNX’s TA Score has 2 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 5 bearish.
  • RGNX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than RGNX.

Price Growth

CRSP (@Biotechnology) experienced а +31.80% price change this week, while RGNX (@Biotechnology) price change was +3.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

CRSP is expected to report earnings on May 12, 2025.

RGNX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.11B) has a higher market cap than RGNX($361M). CRSP YTD gains are higher at: 32.673 vs. RGNX (-1.940). RGNX has higher annual earnings (EBITDA): -217.82M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. RGNX (255M). RGNX has less debt than CRSP: RGNX (84.1M) vs CRSP (228M). CRSP has higher revenues than RGNX: CRSP (200M) vs RGNX (84.3M).
CRSPRGNXCRSP / RGNX
Capitalization4.11B361M1,138%
EBITDA-313.08M-217.82M144%
Gain YTD32.673-1.940-1,684%
P/E RatioN/AN/A-
Revenue200M84.3M237%
Total Cash1.94B255M759%
Total Debt228M84.1M271%
FUNDAMENTALS RATINGS
CRSP vs RGNX: Fundamental Ratings
CRSP
RGNX
OUTLOOK RATING
1..100
2668
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
4465
P/E GROWTH RATING
1..100
8124
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (69) in the Biotechnology industry is in the same range as RGNX (75). This means that CRSP’s stock grew similarly to RGNX’s over the last 12 months.

CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RGNX (100). This means that CRSP’s stock grew similarly to RGNX’s over the last 12 months.

CRSP's SMR Rating (94) in the Biotechnology industry is in the same range as RGNX (98). This means that CRSP’s stock grew similarly to RGNX’s over the last 12 months.

CRSP's Price Growth Rating (44) in the Biotechnology industry is in the same range as RGNX (65). This means that CRSP’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's P/E Growth Rating (24) in the Biotechnology industry is somewhat better than the same rating for CRSP (81). This means that RGNX’s stock grew somewhat faster than CRSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPRGNX
RSI
ODDS (%)
Bearish Trend 6 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 6 days ago
85%
Bullish Trend 6 days ago
75%
Momentum
ODDS (%)
Bullish Trend 6 days ago
78%
Bearish Trend 6 days ago
86%
MACD
ODDS (%)
Bullish Trend 6 days ago
75%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
78%
Bearish Trend 6 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
75%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 24 days ago
74%
Declines
ODDS (%)
Bearish Trend 17 days ago
84%
Bearish Trend 13 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
82%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+5.03%
BEAM - CRSP
70%
Closely correlated
+3.36%
PRME - CRSP
64%
Loosely correlated
+5.28%
RXRX - CRSP
64%
Loosely correlated
+1.04%
NTLA - CRSP
63%
Loosely correlated
+7.76%
EDIT - CRSP
60%
Loosely correlated
+26.09%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with BEAM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
+3.84%
BEAM - RGNX
50%
Loosely correlated
+3.36%
DNLI - RGNX
49%
Loosely correlated
+1.97%
RCKT - RGNX
48%
Loosely correlated
+3.15%
CRSP - RGNX
48%
Loosely correlated
+5.03%
FATE - RGNX
48%
Loosely correlated
+7.75%
More